SPY311.36-0.82 -0.26%
DIA263.33+0.16 0.06%
IXIC9,615.81-67.10 -0.69%
ViewRay Announces Equity Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
ViewRay, Inc. (Nasdaq: VRAY) announced today grants of stock options and restricted stock units to Zach Stassen, Chief Financial Officer for the company. These awards were granted as an inducement material to entering into employment with ViewRay, in accordanc
PR Newswire · 1d ago
Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Contact the Firm; Should Management be Held Accountable for Investors' Losses?
PR Newswire · 1d ago
ViewRay® to Present at the Jefferies 2020 Virtual Healthcare Conference
ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will present at the Jefferies 2020 Virtual Healthcare Conference. Scott Drake, President and CEO, will participate in a fireside chat at 2:30 p.m. Eastern Time on Tuesday, June 2, 2020.
PR Newswire · 05/28 12:00
Providence Portland Medical Center Begins Patient Treatments with ViewRay's MRIdian Linac
PR Newswire · 05/27 11:30
Edited Transcript of VRAY earnings conference call or presentation 30-Apr-20 8:30pm GMT
Q1 2020 ViewRay Inc Earnings Call
Thomson Reuters StreetEvents · 05/18 16:31
Tracking Kahn Brothers Portfolio - Q1 2020 Update
Seeking Alpha - Article · 05/14 10:02
At Look at the Deep Value Stocks of Kahn Brothers
GuruFocus.com · 05/13 16:57
Did ViewRay, Inc. (NASDAQ:VRAY) Insiders Buy Up More Shares?
Simply Wall St. · 05/12 15:21
Kahn Brothers Buys Buffett's JPMorgan During the 1st Quarter
GuruFocus.com · 05/11 23:56
Oppenheimer Maintains Outperform on ViewRay, Lowers Price Target to $3
Oppenheimer maintains ViewRay (NASDAQ:VRAY) with a Outperform and lowers the price target from $4.5 to $3.
Benzinga · 05/01 12:55
ViewRay's (VRAY) CEO Scott Drake on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/01 02:51
ViewRay (VRAY) Reports Q1 Loss, Tops Revenue Estimates
Zacks · 04/30 23:25
ViewRay Names Zach Stassen as Chief Financial Officer
Benzinga · 04/30 20:13
ViewRay Q1 EPS $(0.190) Misses $(0.180) Estimate, Sales $14.300M Beat $12.550M Estimate
ViewRay (NASDAQ:VRAY) reported quarterly losses of $(0.190) per share which missed the analyst consensus estimate of $(0.180) by 5.56 percent. The company reported quarterly sales of $14.300 million which beat the
Benzinga · 04/30 20:12
Benzinga's Top Upgrades, Downgrades For April 28, 2020
Benzinga · 04/28 13:32
Wells softens view on Edwards Lifesciences in premarket analyst action
Seeking Alpha - Article · 04/28 11:32
Guggenheim Downgrades ViewRay to Neutral
Guggenheim analyst Christopher Pasquale downgrades ViewRay (NASDAQ:VRAY) from Buy to Neutral.
Benzinga · 04/28 11:31
ViewRay (VRAY) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Zacks · 04/23 17:32
The Zacks Analyst Blog Highlights: Eli Lilly, DexCom, ViewRay, Chemed and Sage Therapeutics
Zacks · 04/22 16:09
Buy 5 Top Health Care Stocks Ahead of Q1 Earnings Results
Zacks · 04/21 12:39